Onconic Therapeutics Inc. (KOSDAQ:476060)
10,210
-730 (-6.67%)
Nov 20, 2026, 3:30 PM KST
Onconic Therapeutics Market Cap
Onconic Therapeutics has a market cap or net worth of 463.61 billion as of November 20, 2026. It is the 16,335th most valuable company in the world and the 438th biggest in South Korea. Its market cap has decreased by 33.88% in one year.
Market Cap
463.61B
Enterprise Value
401.27B
Revenue
82.17B
Global Rank
Country Rank
#438 South Korea
PE Ratio
19.32
ChartMarket Cap Chart
Since December 19, 2024, Onconic Therapeutics's market cap has increased from 186.91B to 463.61B, an increase of 148.04%. That is a compound annual growth rate of 60.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 463.61B | -46.70% |
| Dec 30, 2025 | 869.78B | 392.69% |
| Dec 30, 2024 | 176.54B | -5.55% |
| Dec 19, 2024 | 186.91B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chabiotech | 676.19B |
| Proteina | 645.56B |
| Komipharm International | 598.76B |
| Hyundai Bioscience | 585.78B |
| Pharmicell | 469.23B |
| AbClon | 465.88B |
| Medy-Tox | 446.91B |
| GI Innovation | 427.10B |